US Stock MarketDetailed Quotes
ADTX Aditxt
- 0.4760
- +0.0105+2.26%
Close Sep 9 16:00 ET
- 0.4750
- -0.0010-0.21%
Post 20:02 ET
1.71MMarket Cap-13P/E (TTM)
0.5300High0.4600Low366.98KVolume0.4800Open0.4655Pre Close180.30KTurnover10.21%Turnover RatioLossP/E (Static)3.60MShares24.000052wk High0.26P/B1.71MFloat Cap0.416452wk Low--Dividend TTM3.59MShs Float19160.0000Historical High--Div YieldTTM15.04%Amplitude0.4164Historical Low0.4910Avg Price1Lot Size
About Aditxt Company
Aditxt, Inc. is a biotech innovation company, which engages in the development and commercialization of technologies focusing on monitoring and modulating the immune system. Its innovation portfolio includes Adimune and AditxtScore. The company was founded by Leonard L. Bailey, Shahrokh Shabahang, and Amro Albanna on September 28, 2017 and is headquartered in Richmond, VA.
Company Profile
SymbolADTX
Company NameAditxt
Listing DateJun 30, 2020
Founded2017
CEOMr. Amro A. Albanna
MarketNASDAQ
Employees47
Fiscal Year Ends12-31
Address737 North Fifth Street,Suite 200
CityRichmond
ProvinceVirginia
CountryUnited States of America
Zip Code23219
Phone1-650-870-1200
Websitehttp://www.aditxt.com
Company Executives
- Name
- Position
- Salary
- Amro A. Albanna
- Chairman of the Board and Chief Executive Officer
- 519.23K
- Rowena Albanna
- Chief Operating Officer
- --
- Corinne Pankovcin
- Chief Mergers and Acquisitions Officer
- 390.33K
- Thomas J. Farley
- Chief Financial Officer and Principal Accounting Officer
- 381.45K
- Dr. Shahrokh Shabahang, D.D.S.,M.S.,PhD
- Director and Chief Innovation Officer
- 358.84K
- Charles Athle Nelson
- Independent Director
- --
- Brian Brady
- Independent Director
- 3.86K
- Dr. Jeffrey W. Runge, M.D.
- Independent Director
- 3.86K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg